Literature DB >> 28128698

Leptomeningeal dissemination of a low-grade lumbar paraganglioma: case report.

Nick Thomson1, Karel Pacak2, Meic Schmidt3,4, Cheryl Palmer5,4, Karen Salzman6,4, Marjan Champine4,7, Joshua Schiffman8,4, Adam Cohen9,4.   

Abstract

Leptomeningeal dissemination of paraganglioma is rare, with only 2 prior cases in the literature. The authors present the case of a metastatic low-grade lumbar paraganglioma via leptomeningeal dissemination. This report emphasizes the utility of 3,4-dihydroxy-6-18F-fluoro-l-phenylalanine (18F-FDOPA) PET scanning for diagnosis, as well as the combination of radiation therapy and alkylating chemotherapeutic agents for the treatment of this rare phenomenon. The patient was a 61-year-old woman who presented with low-back pain and was found to have an isolated L-3 intrathecal tumor on MRI. Sixteen months after gross-total en bloc resection of the paraganglioma, the patient again became symptomatic with new neurological symptoms. MRI findings revealed enhancing leptomeningeal nodules throughout the spine. 18F-FDOPA PET/CT scanning was used to confirm the diagnosis of disseminated paraganglioma. Intrathecal thiotepa, radiation therapy, and systemic therapy with capecitabine and temozolomide have been used sequentially over a 2-year period, with each able to stabilize tumor growth for several months. The authors also summarize the 2 other reports of leptomeningeal dissemination of paragangliomas in the literature and compare the course and management of the 3 cases.

Entities:  

Keywords:  18F-FDOPA = 3,4-dihydroxy-6-18F-fluoro-l-phenylalanine; 18F-FLT = 3′-deoxy-3′-18F-fluorothymidine; lumbar; metastasis; neuroendocrine tumor; oncology; paraganglioma; spinal neoplasm

Mesh:

Year:  2017        PMID: 28128698      PMCID: PMC5378641          DOI: 10.3171/2016.10.SPINE16948

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  27 in total

1.  G12S and H50R variations are polymorphisms in the SDHD gene.

Authors:  Alberto Cascón; Sergio Ruiz-Llorente; Arancha Cebrián; Rocío Letón; Dolores Tellería; Javier Benítez; Mercedes Robledo
Journal:  Genes Chromosomes Cancer       Date:  2003-06       Impact factor: 5.006

Review 2.  15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma.

Authors:  Frédéric Castinetti; Alexander Kroiss; Rakesh Kumar; Karel Pacak; David Taieb
Journal:  Endocr Relat Cancer       Date:  2015-06-04       Impact factor: 5.678

3.  Surgical resection of carotid body tumors: long-term survival, recurrence, and metastasis.

Authors:  J D Nora; J W Hallett; P C O'Brien; J M Naessens; K J Cherry; P C Pairolero
Journal:  Mayo Clin Proc       Date:  1988-04       Impact factor: 7.616

4.  18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.

Authors:  Elise M Blanchet; David Taieb; Corina Millo; Victoria Martucci; Clara C Chen; Maria Merino; Peter Herscovitch; Karel Pacak
Journal:  J Nucl Med       Date:  2015-09-10       Impact factor: 10.057

5.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  Local-regional recurrence of sporadic or syndromic abdominal extra-adrenal paraganglioma: incidence, characteristics, and outcome.

Authors:  Sam Van Slycke; Robert Caiazzo; Pascal Pigny; Catherine Cardot-Bauters; Laurent Arnalsteen; Michele D'Herbomez; Emmanuelle Leteurtre; Nathalie Rouaix-Emery; Olivier Ernst; Damien Huglo; Marie-Christine Vantyghem; Jean-Louis Wemeau; Bruno Carnaille; François Pattou
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

7.  Treatment of malignant pheochromocytoma.

Authors:  H Drasin
Journal:  West J Med       Date:  1978-02

Review 8.  Role of (18) F-FDOPA PET/CT imaging in endocrinology.

Authors:  Prasanna Santhanam; David Taïeb
Journal:  Clin Endocrinol (Oxf)       Date:  2014-09-01       Impact factor: 3.478

9.  Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.

Authors:  Lauren Fishbein; Shana Merrill; Douglas L Fraker; Debbie L Cohen; Katherine L Nathanson
Journal:  Ann Surg Oncol       Date:  2013-03-20       Impact factor: 5.344

10.  The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.

Authors:  Jan Schovanek; Victoria Martucci; Robert Wesley; Tito Fojo; Jaydira Del Rivero; Thanh Huynh; Karen Adams; Electron Kebebew; Zdenek Frysak; Constantine A Stratakis; Karel Pacak
Journal:  BMC Cancer       Date:  2014-07-21       Impact factor: 4.430

View more
  3 in total

Review 1.  Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review.

Authors:  Yasushi Fujiwara; Hideki Manabe; Bunichiro Izumi; Takayuki Shima; Nobuo Adachi
Journal:  Eur Spine J       Date:  2017-12-21       Impact factor: 3.134

Review 2.  Leptomeningeal disease: current diagnostic and therapeutic strategies.

Authors:  Gautam Nayar; Tiffany Ejikeme; Pakawat Chongsathidkiet; Aladine A Elsamadicy; Kimberly L Blackwell; Jeffrey M Clarke; Shivanand P Lad; Peter E Fecci
Journal:  Oncotarget       Date:  2017-08-16

3.  Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms.

Authors:  Leonidas Apostolidis; Jörg Schrader; Henning Jann; Anja Rinke; Sebastian Krug
Journal:  Biology (Basel)       Date:  2021-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.